Educating Providers About Lung Screening
We are conducting a randomized trial to compare the Health Disparities module to an existing provider module on lung cancer screening to evaluate the impact on primary care providers' knowledge, attitudes, and lung cancer screening referrals of African American and White patients.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Aug 5, 2022 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Georgetown University
- Interventions being studied
- Behavioral: LuCa + Health Disparity module
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- MedStar provider (attending or resident physician, physician's assistant, or nurse practitioner)
- English speaking
- ability to provide meaningful consent
- ability to provide last two digits of NPI.
N/A
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- MedStar Health Georgetown University HospitalWashington D.C., District of Columbia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 5, 2022. Always confirm current availability with the study team.